SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine

SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine

Background: At variance to humoral responses, cellular immunity after anti-SARS-CoV-2 vaccines has been poorly explored in recipients of allogeneic hematopoietic stem-cell transplantation (Allo-HSCT), especially within the first post-transplant years where immunosuppression is more profound and harm...

Full description

Bibliographic Details
Main Authors: Béatrice Clémenceau, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie C. Béné, Henri Vié, Patrice Chevallier
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
COVID 19
vaccine
BNT162b2
SARS-CoV-2 mRNA
allogeneic hematopoietic stem cell transplantation
cellular immunity
Online Access:https://www.mdpi.com/2076-393X/10/3/448

Internet

https://www.mdpi.com/2076-393X/10/3/448

Similar Items